FDA’s Busy Summer (So Far)

Life Sciences Webinar

August 11, 2026 | 12:00 PM ET

No summertime slowdown here – The FDA has been exceptionally busy in the last month, with the release of important new regulatory proposals, major guidance documents, new actions on longstanding priorities, and ongoing leadership questions. On Capitol Hill, lawmakers have introduced – and are advancing – legislative proposals that could shape the agency for years to come as the annual appropriations process proceeds and as lawmakers prepare for the upcoming user fee reauthorization process.

Join AgencyIQ by POLITICO’s Life Sciences team for a lively, informative, and actionable webinar exploring the FDA’s latest regulatory changes affecting the pharmaceuticals, biopharmaceutical, medical device, and diagnostics industries. We’ll explore the latest regulations, guidances, major policy developments and policy agendas. Plus, our experts will be on hand to answer your questions live.